FDA Inspection 989833 — BASF SE
The FDA completed an inspection of BASF SE on March 10, 2016 in Ludwigshafen Am Rhein. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 10, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ludwigshafen Am Rhein (Germany)